INSPIREMD, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.382 USD | -0.75% |
|
+12.36% | -15.23% |
| 14/05 | Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M | MT |
| 06/03 | Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024 |
Chart calendar InspireMD, Inc.
0.YJLwvaIYrDNdLynLoPihRzdwSaR_TsC-XHjrEpOl5NA.VfaV1dpu1FIeRlOZ8bzJMholOPMTF47_NDWiK-nd1-YG0JHP-2DlcB4YWg~02fc8ada9796c9de937375b989f863d3
Upcoming events on InspireMD, Inc.
Past events on InspireMD, Inc.
| 14/05/2024 06:00 pm | Q1 2024 Earnings Call |
| 14/05/2024 04:30 pm | Q1 2024 Earnings Release |
| 10/04/2024 05:30 pm | Needham Healthcare Conference |
| 06/03/2024 07:00 pm | Q4 2023 Earnings Call |
| 06/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 25/02/2024 | ICI Meeting |
| 10/12/2023 | ICI Conference |
| 04/12/2023 | BRAIN Conference |
| 29/11/2023 06:30 pm | Piper Healthcare Conference |
| 16/11/2023 | Canaccord Genuity MedTech, Diagnostics, Digital Health & Services Conference |
| 15/11/2023 11:00 pm | Wolfe Research Healthcare Conference |
| 14/11/2023 | Veith Symposium |
| 08/11/2023 | PVI Conference |
| 06/11/2023 07:00 pm | Q3 2023 Earnings Call |
| 06/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 01/11/2023 11:15 pm | Vascular InterVentional Advances Meeting |
| 30/10/2023 | VIVA Conference |
| 23/10/2023 | TCT Conference |
| 18/10/2023 | SOBRICE Conference |
| 20/09/2023 | ESVS Belfast Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,72 4,30 -13.47% | 2,49 3,25 -23.54% | 4,50 4,50 -0.11% | 5,17 5,00 3.42% | 6,21 6,10 1.76% | 7,09 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -16,4 -19,5 15.71% | -20,7 |
|
EBIT Million USD | Released Forecast Spread | -9,82 -9,30 -5.55% | -10,4 -9,20 -12.83% | -14,7 -17,0 13.44% | 0,00 0,00 - | -21,1 -22,4 5.62% | -25,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -10,5 -9,60 -9.79% | -14,9 -16,9 11.99% | 0,00 0,00 - | -19,9 -21,1 5.92% | 0,00 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -10,5 -9,60 -9.83% | -14,9 -16,9 11.73% | 0,00 0,00 - | -19,9 -21,1 5.61% | 0,00 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -6,90 -6,60 -4.55% | -2,03 -2,30 11.74% | -2,35 -2,59 9.27% | -0,82 -0,87 5.75% | 0,00 |
| Announcement Date | 10/03/20 | 08/03/21 | 07/03/22 | 30/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,38 1,30 6.15% | 1,18 1,40 -15.5% | 1,53 1,20 27.58% | 1,43 1,40 2.21% | 1,03 1,00 2.6% | 1,24 1,00 23.9% | 1,65 1,55 6.66% | 1,56 1,50 3.87% | 1,76 1,63 8.34% | 1,51 1,38 9.18% | 1,88 | 1,69 | 2,14 | 2,35 |
|
EBITDA Million USD | Released Forecast Spread | -5,26 -4,95 -6.12% | -5,58 -4,96 -12.45% | -4,10 -6,27 34.67% | -7,35 -4,28 -71.73% | -5,19 | -4,56 | -6,69 | -5,90 | ||||||
|
EBIT Million USD | Released Forecast Spread | -3,93 -6,20 36.6% | -4,49 -6,20 27.65% | -4,68 -6,10 23.26% | -4,61 -6,10 24.43% | -4,38 -5,80 24.47% | -5,32 -5,82 8.75% | -5,64 -5,43 -3.87% | -5,81 -7,08 18.01% | -7,41 -5,34 -38.92% | -6,26 | -5,63 | -7,74 | -7,17 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,05 -6,10 33.57% | -4,48 -6,30 28.87% | -4,64 -6,10 24% | -4,53 -6,10 25.75% | -4,26 -5,70 25.33% | -5,08 -5,80 12.47% | -5,18 -4,90 -5.67% | -5,34 -6,60 19.09% | ||||||
|
Net income Million USD | Released Forecast Spread | -4,10 -6,10 32.84% | -4,48 -6,30 28.87% | -4,64 -6,10 24% | -4,53 -6,10 25.75% | -4,26 -5,70 25.33% | -5,08 -5,80 12.47% | -5,18 -4,90 -5.67% | -5,41 -6,60 18.11% | ||||||
|
EPS USD | Released Forecast Spread | -0,53 -0,78 32.05% | -0,57 -0,80 28.75% | -0,59 -0,73 19.18% | -0,58 -0,73 20.55% | -0,60 -0,84 28.57% | -0,53 -0,68 22.06% | -0,24 -0,43 44.19% | -0,15 -0,14 -7.14% | -0,13 -0,19 31.58% | |||||
| Announcement Date | 07/03/22 | 09/05/22 | 08/08/22 | 07/11/22 | 30/03/23 | 15/05/23 | 07/08/23 | 06/11/23 | 05/03/24 | 13/05/24 | - | - | - | - |
| 16/05/2024 11:30 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 22/05/2024 10:30 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
| 23/05/2024 04:15 pm | MEDTRONIC PLC: Q4 2024 Earnings Release |
| 24/05/2024 05:30 pm | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
| 29/05/2024 02:30 am | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
| 19/06/2024 | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release (Projected) |
| 27/06/2024 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
| 04/07/2024 | MANI, INC.: Q3 2024 Earnings Release (Projected) |
| 11/07/2024 10:30 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
| 12/07/2024 | ARJO AB: Q2 2024 Earnings Release |
Past sector events for InspireMD, Inc.
| Today | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today | HOYA CORPORATION: Q4 2023 Earnings Release |
| 14/05/2024 10:30 am | AMBU A/S: Q2 2024 Earnings Release |
| 14/05/2024 | HLB CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 14/05/2024 | TERUMO CORPORATION: Q4 2023 Earnings Release |
| 14/05/2024 | ALFRESA HOLDINGS CORPORATION: Q4 2023 Earnings Release |
| 13/05/2024 | PARAMOUNT BED HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
| 11/05/2024 01:40 am | ATRION CORPORATION: Q1 2024 Earnings Release |
| 10/05/2024 | NIPRO CORPORATION: Q4 2023 Earnings Release |
| 10/05/2024 | PHC HOLDINGS CORPORATION: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NSPR Stock
- Calendar InspireMD, Inc.